Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 191 articles:
HTML format



Single Articles


    April 2021
  1. BEHRENBRUCH C, Prabhakaran S, Udayasiri D D, Michael M, et al
    Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study.
    J Surg Oncol. 2021;123:1263-1273.
    PubMed     Abstract available


    March 2021
  2. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    PubMed     Abstract available


  3. LEIPHRAKPAM PD, Lazenby AJ, Smith LM, Brattain MG, et al
    Stathmin expression in metastatic colorectal cancer.
    J Surg Oncol. 2021 Mar 25. doi: 10.1002/jso.26464.
    PubMed     Abstract available


  4. LUMISH MA, Cercek A
    Immunotherapy for the treatment of colorectal cancer.
    J Surg Oncol. 2021;123:760-774.
    PubMed     Abstract available


  5. SUN Y, Zhang D, Feng Y, Wang Y, et al
    Infrapyloric lymph node dissection in right hemicolectomy for colon cancer: Should prophylactic resection be recommended?
    J Surg Oncol. 2021 Mar 1. doi: 10.1002/jso.26388.
    PubMed     Abstract available


  6. GRASS F, Merchea A, Mathis KL, Mishra N, et al
    Cost drivers of locally advanced rectal cancer treatment-An analysis of a leading healthcare insurer.
    J Surg Oncol. 2021;123:1023-1029.
    PubMed     Abstract available


  7. DENADAI MVA, Melani AGF, Neto MC, Romagnolo LGC, et al
    Robotic rectal surgery: Outcomes of the first 102 totally robotic cases handled using the single-docking technique in a reference institution.
    J Surg Oncol. 2021;123:997-1004.
    PubMed     Abstract available


    February 2021
  8. WILLIAMS AD, Sun T, Kakade S, Wong SL, et al
    Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure.
    J Surg Oncol. 2021 Feb 12. doi: 10.1002/jso.26298.
    PubMed     Abstract available


  9. LE VH, Thornblade L, Ituarte PHG, Lai LL, et al
    Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.
    J Surg Oncol. 2021;123:622-629.
    PubMed     Abstract available


  10. MURPHY C, Stephens I, OFlanagan G, OByrne L, et al
    A comparison of oncological outcomes after abdominoperineal excision before and after the implementation of a selective perineal flap closure program.
    J Surg Oncol. 2021;123:614-621.
    PubMed     Abstract available


    January 2021
  11. ISHIMARU K, Kawai K, Nozawa H, Sasaki K, et al
    Hazard function analysis of metastatic recurrence after colorectal cancer surgery-A nationwide retrospective study.
    J Surg Oncol. 2021 Jan 14. doi: 10.1002/jso.26378.
    PubMed     Abstract available


  12. KAMPHUES C, Andreatos N, Kruppa J, Buettner S, et al
    The optimal cut-off values for tumor size, number of lesions, and CEA levels in patients with surgically treated colorectal cancer liver metastases: An international, multi-institutional study.
    J Surg Oncol. 2021 Jan 5. doi: 10.1002/jso.26361.
    PubMed     Abstract available


  13. DE NARDI P, Mistrangelo M, Burtulo G, Passoni P, et al
    Tailoring the radiotherapy approach in patients with anal squamous cell carcinoma based on inguinal sentinel lymph node biopsy.
    J Surg Oncol. 2021;123:315-321.
    PubMed     Abstract available


  14. LEIPHRAKPAM PD, Chowdhury S, Wang J, Black JD, et al
    The role and therapeutic implications of PI3K signaling pathway in cancer.
    J Surg Oncol. 2021;123:39-41.
    PubMed    


  15. EL ASMAR A, Veys I, Larsimont D, Donckier V, et al
    Inferior epigastric artery lymph nodes: A pathway for systemic dissemination from peritoneal carcinomatosis?
    J Surg Oncol. 2021;123:311-314.
    PubMed     Abstract available


  16. ROUANET P, Rivoire M, Gourgou S, Lelong B, et al
    Sphincter-saving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up?
    J Surg Oncol. 2021;123:299-310.
    PubMed     Abstract available


  17. MUADDI H, D'Angelica M, Wiseman JT, Dillhoff M, et al
    Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
    J Surg Oncol. 2021;123:252-260.
    PubMed     Abstract available


  18. CHUAN L, Linfeng G, Hongchang L, Xiaosong W, et al
    Short-term outcomes of pelvic floor peritoneum closure in endoscopic low anterior resection of rectal cancer: A propensity score matching analysis.
    J Surg Oncol. 2021;123:271-277.
    PubMed     Abstract available


  19. SELL NM, Qwaider YZ, Goldstone RN, Cauley CE, et al
    Ten-year survival after pathologic complete response in rectal adenocarcinoma.
    J Surg Oncol. 2021;123:293-298.
    PubMed     Abstract available


  20. KOIZUMI M, Yamada T, Shinji S, Matsuda A, et al
    Even a partial pathological response is associated with lower relapse rates in patients with operable rectal cancer undergoing neoadjuvant chemotherapy.
    J Surg Oncol. 2021;123:286-292.
    PubMed     Abstract available


  21. ZHOU P, Goffredo P, Ginader T, Thompson D, et al
    Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer.
    J Surg Oncol. 2021;123:278-285.
    PubMed     Abstract available


  22. LEE RM, Gamboa AC, Turgeon MK, Zaidi MY, et al
    A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
    J Surg Oncol. 2021;123:187-195.
    PubMed     Abstract available


  23. MCKENNA NP, Bews KA, Colibaseanu DT, Mathis KL, et al
    The intersection of tumor location and combined bowel preparation: Utilization differs but anastomotic leak risk reduction does not.
    J Surg Oncol. 2021;123:261-270.
    PubMed     Abstract available


    December 2020
  24. KAMPHUES C, Kadowaki S, Amini N, van den Berg I, et al
    The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
    J Surg Oncol. 2020 Dec 23. doi: 10.1002/jso.26352.
    PubMed     Abstract available


  25. PARK YY, Lee J, Han YD, Cho MS, et al
    Survival outcomes after isolated local recurrence of rectal cancer and risk analysis affecting its resectability.
    J Surg Oncol. 2020;122:1470-1480.
    PubMed     Abstract available


  26. BENOIT O, Svrcek M, Creavin B, Bouquot M, et al
    Prognostic value of tumor deposits in rectal cancer: A monocentric series of 505 patients.
    J Surg Oncol. 2020;122:1481-1489.
    PubMed     Abstract available


  27. SROUJI RM, Narayan RR, Boerner T, Buisman FE, et al
    Extrahepatic recurrence rates in patients receiving adjuvant hepatic artery infusion and systemic chemotherapy after complete resection of colorectal liver metastases.
    J Surg Oncol. 2020;122:1536-1542.
    PubMed     Abstract available


  28. SAKAMOTO T, Hida K, Hoshino N, Yamaguchi T, et al
    Changes in the sexual function of male patients with rectal cancer over a 2-year period from diagnosis to 24-month follow-up: A prospective, multicenter, cohort study.
    J Surg Oncol. 2020;122:1647-1654.
    PubMed     Abstract available


  29. VASAN K, Anand S, Satgunaseelan L, Asher R, et al
    Mismatch repair protein loss in cutaneous head and neck squamous cell carcinoma.
    J Surg Oncol. 2020;122:1755-1760.
    PubMed     Abstract available


    November 2020
  30. PATA G, Bianchetti L, Rota M, Marengoni A, et al
    Multidimensional Prognostic Index (MPI) score has the major impact on outcome prediction in elderly surgical patients with colorectal cancer: The FRAGIS study.
    J Surg Oncol. 2020 Nov 25. doi: 10.1002/jso.26314.
    PubMed     Abstract available


  31. LEIPHRAKPAM PD, Lazenby AJ, Smith LM, Brattain MG, et al
    Correlation of PRL3 expression with colorectal cancer progression.
    J Surg Oncol. 2020 Nov 12. doi: 10.1002/jso.26253.
    PubMed     Abstract available


  32. AZIN A, Hirpara DH, Draginov A, Khorasani M, et al
    Adequacy of lymph node harvest following colectomy for obstructed and nonobstructed colon cancer.
    J Surg Oncol. 2020 Nov 3. doi: 10.1002/jso.26274.
    PubMed     Abstract available


  33. AUGUSTIN T, Moslim MA, Cengiz TB, El-Hayek K, et al
    Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer.
    J Surg Oncol. 2020;122:1132-1144.
    PubMed     Abstract available


  34. GIESEN LJX, Borstlap WAA, Bemelman WA, Tanis PJ, et al
    Effect of understaging on local recurrence of rectal cancer.
    J Surg Oncol. 2020;122:1179-1186.
    PubMed     Abstract available


    October 2020
  35. ALESE OB, Zakka K, Huo X, Jiang R, et al
    Perioperative therapy in metastatic colorectal cancer: Pattern of use and survival outcomes.
    J Surg Oncol. 2020 Oct 30. doi: 10.1002/jso.26278.
    PubMed     Abstract available


  36. SUAREZ J, Mata E, Guerra A, Jimenez G, et al
    Impact of the COVID-19 pandemic during Spain's state of emergency on the diagnosis of colorectal cancer.
    J Surg Oncol. 2020 Oct 19. doi: 10.1002/jso.26263.
    PubMed     Abstract available


  37. HAMID HKS
    Considerations for transanal surgery during COVID-19 pandemic.
    J Surg Oncol. 2020;122:995.
    PubMed    


  38. DE CRIGNIS L, Slim K, Cotte E, Meillat H, et al
    Impact of surgical indication on patient outcomes and compliance with enhanced recovery program for colorectal surgery: A Francophone multicenter retrospective analysis.
    J Surg Oncol. 2020;122:928-933.
    PubMed     Abstract available


  39. NICHOLS DS, Satteson E, Harbor P, DeFranzo A, et al
    Factors associated with the use of vertical rectus abdominus myocutaneous flap reconstruction following abdominoperineal resection for anorectal cancer.
    J Surg Oncol. 2020;122:923-927.
    PubMed     Abstract available


    September 2020
  40. RAOOF M, Fong Y
    Liver resection for colorectal cancer liver metastases: An often-neglected opportunity for cure.
    J Surg Oncol. 2020 Sep 24. doi: 10.1002/jso.26192.
    PubMed    


  41. RAJ KUMAR B, Pandey D, Rohila J, deSouza A, et al
    An observational study of the demographic and treatment changes in a tertiary colorectal cancer center during the COVID-19 pandemic.
    J Surg Oncol. 2020 Sep 3. doi: 10.1002/jso.26193.
    PubMed     Abstract available


  42. KAWAKATSU S, Mise Y, Hiratsuka M, Inoue Y, et al
    Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases.
    J Surg Oncol. 2020;122:523-528.
    PubMed     Abstract available


    August 2020
  43. PARK Y, Kim DW, Hong YJ, Park KU, et al
    Is elevated microsatellite alterations at selected tetranucleotide repeats (EMAST)-negative/MSI-high colorectal cancer a distinct subtype of the disease?
    J Surg Oncol. 2020 Aug 10. doi: 10.1002/jso.26157.
    PubMed     Abstract available


  44. SEBASTIAN-TOMAS JC, Domingo-Del Pozo C, Gomez-Abril SA, Navarro-Martinez S, et al
    Laparoscopic staged colon-first resection for metastatic colorectal cancer: Perioperative and midterm outcomes from a single-center experience.
    J Surg Oncol. 2020 Aug 10. doi: 10.1002/jso.26152.
    PubMed     Abstract available


  45. BELLI F, Sorrentino L, Gallino G, Gronchi A, et al
    A proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision-making.
    J Surg Oncol. 2020;122:350-359.
    PubMed     Abstract available


  46. FERNANDEZ-MORENO MC, Dorcaratto D, Garces-Albir M, Munoz E, et al
    Impact of type and severity of postoperative complications on long-term outcomes after colorectal liver metastases resection.
    J Surg Oncol. 2020;122:212-225.
    PubMed     Abstract available


    July 2020
  47. BEDNARSKI BK
    Minimally invasive rectal surgery: Laparoscopy, robotics, and transanal approaches.
    J Surg Oncol. 2020;122:78-84.
    PubMed    


  48. THIELS CA, D'Angelica MI
    Hepatic artery infusion pumps.
    J Surg Oncol. 2020;122:70-77.
    PubMed     Abstract available


    June 2020
  49. BINGMER K, Ofshteyn A, Bliggenstorfer JT, Kethman W, et al
    Primary tumor location impacts survival in colorectal cancer patients after resection of liver metastases.
    J Surg Oncol. 2020 Jun 10. doi: 10.1002/jso.26061.
    PubMed     Abstract available


  50. BINGMER K, Kondray V, Ofshteyn A, Bliggenstorfer JT, et al
    Sarcopenia is associated with worse overall survival in patients with anal squamous cell cancer.
    J Surg Oncol. 2020;121:1148-1153.
    PubMed     Abstract available


  51. YANG J, Chen Q, Jindou L, Cheng Y, et al
    The influence of anastomotic leakage for rectal cancer oncologic outcome: A systematic review and meta-analysis.
    J Surg Oncol. 2020;121:1283-1297.
    PubMed     Abstract available


  52. SROUJI R, Narayan R, Boerner T, Buisman F, et al
    Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.
    J Surg Oncol. 2020;121:1314-1319.
    PubMed     Abstract available


  53. STEIN MK, Williard FW, Xiu J, Tsao MW, et al
    Comprehensive tumor profiling reveals unique molecular differences between peritoneal metastases and primary colorectal adenocarcinoma.
    J Surg Oncol. 2020;121:1320-1328.
    PubMed     Abstract available


    May 2020
  54. SORRENTINO L, Guaglio M, Cosimelli M
    Elective colorectal cancer surgery at the oncologic hub of Lombardy inside a pandemic COVID-19 area.
    J Surg Oncol. 2020 May 31. doi: 10.1002/jso.26052.
    PubMed    


  55. RUEFF J, Weixler B, Viehl CT, Ochsner A, et al
    Improved quality of colon cancer surveillance after implementation of a personalized surveillance schedule.
    J Surg Oncol. 2020 May 14. doi: 10.1002/jso.25973.
    PubMed     Abstract available


  56. FIELDS AC, Lu PW, Yoo J, Irani J, et al
    Treatment of stage I-III rectal cancer: Who is refusing surgery?
    J Surg Oncol. 2020;121:990-1000.
    PubMed     Abstract available


    April 2020
  57. MIYAMOTO Y, Hiyoshi Y, Tokunaga R, Akiyama T, et al
    Postoperative complications are associated with poor survival outcome after curative resection for colorectal cancer: A propensity-score analysis.
    J Surg Oncol. 2020 Apr 28. doi: 10.1002/jso.25961.
    PubMed     Abstract available


  58. VAZ DA SILVA DG, Ribeiro HSC, Arra DASM, Torres SM, et al
    Predictors of long-term survival in patients with hepatic resection of colorectal metastases: Analysis of a Brazilian Cancer Center Cohort.
    J Surg Oncol. 2020;121:893-900.
    PubMed     Abstract available


  59. ARAUJO RLC, Sanctis MA, Barroti LC, Coelho TRV, et al
    Robotic approach as a valid strategy to improve the access to posterosuperior hepatic segments-Case series and review of literature.
    J Surg Oncol. 2020;121:873-880.
    PubMed     Abstract available


  60. RIBEIRO R, Fontes Cintra G, Barrozo A, Tieko Tsunoda A, et al
    Brazilian Society of Surgical Oncology guidelines for surgical treatment of endometrial cancer in regions with limited resources.
    J Surg Oncol. 2020;121:730-742.
    PubMed     Abstract available


  61. ARAUJO RLC, Milani JM, Armentano DP, Moreira RB, et al
    Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy.
    J Surg Oncol. 2020;121:848-856.
    PubMed     Abstract available


  62. WOESTE MR, Philips P, Egger ME, Scoggins CR, et al
    Optimal perfusion chemotherapy: A prospective comparison of mitomycin C and oxaliplatin for hyperthermic intraperitoneal chemotherapy in metastatic colon cancer.
    J Surg Oncol. 2020 Apr 1. doi: 10.1002/jso.25920.
    PubMed     Abstract available


    March 2020
  63. LU PW, Fields AC, Yoo J, Irani J, et al
    Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.
    J Surg Oncol. 2020 Mar 29. doi: 10.1002/jso.25917.
    PubMed     Abstract available


  64. YUCE TK, Ellis RJ, Chung J, Merkow RP, et al
    Association between surgical approach and survival following resection of abdominopelvic malignancies.
    J Surg Oncol. 2020;121:620-629.
    PubMed     Abstract available


    February 2020
  65. CORSINI EM, Datar SS, Mitchell KG, Zhou N, et al
    High mutational concordance between primary colorectal tumors and associated pulmonary metastases.
    J Surg Oncol. 2020 Feb 19. doi: 10.1002/jso.25871.
    PubMed     Abstract available


  66. SERRANO PE, Gu CS, Moulton CA, Husien M, et al
    Effect of PET-CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long-term results of a randomized controlled trial.
    J Surg Oncol. 2020 Feb 7. doi: 10.1002/jso.25864.
    PubMed     Abstract available


    December 2019
  67. LEIPHRAKPAM PD, Lazenby AJ, Chowdhury S, Smith LM, et al
    Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
    J Surg Oncol. 2019 Dec 22. doi: 10.1002/jso.25805.
    PubMed     Abstract available


  68. LIMA PMA, Torres LC, Martins MR, da Matta MC, et al
    Soluble levels of sCD40L and s4-1BB are associated with a poor prognosis in elderly patients with colorectal cancer.
    J Surg Oncol. 2019 Dec 19. doi: 10.1002/jso.25813.
    PubMed     Abstract available


  69. GOFFREDO P, Zhou P, Ginader T, Hrabe J, et al
    Positive circumferential resection margins following locally advanced colon cancer surgery: Risk factors and survival impact.
    J Surg Oncol. 2019 Dec 18. doi: 10.1002/jso.25801.
    PubMed     Abstract available


  70. GKEKAS I, Novotny J, Fabian P, Nemecek R, et al
    Mismatch repair status predicts survival after adjuvant treatment in stage II colon cancer patients.
    J Surg Oncol. 2019 Dec 11. doi: 10.1002/jso.25798.
    PubMed     Abstract available


  71. FIELDS AC, Welten VM, Lu P, Goldberg JE, et al
    Does race impact survival for patients with anal squamous cell carcinoma?
    J Surg Oncol. 2019;120:1201-1207.
    PubMed     Abstract available


  72. YANG L, Bao J, Jiang Q, Yu DS, et al
    Lower fecal pH may be a novel indicator of pouchitis after IPAA in patients with FAP or metachronous Lynch syndrome.
    J Surg Oncol. 2019;120:1184-1189.
    PubMed     Abstract available


  73. REYNOLDS IS, O'Connell E, Fichtner M, McNamara DA, et al
    Mucinous adenocarcinoma of the colon and rectum: A genomic analysis.
    J Surg Oncol. 2019;120:1427-1435.
    PubMed     Abstract available


  74. KIM JC, Lee JL, Kim CW, Lim SB, et al
    Mechanotechnical faults and particular issues of anastomotic complications following robot-assisted anterior resection in 968 rectal cancer patients.
    J Surg Oncol. 2019;120:1436-1445.
    PubMed     Abstract available


  75. XIAO C, Zhou M, Yang X, Xiao F, et al
    Novel nomogram with microvascular density in the surgical margins can accurately predict the risk for anastomotic leakage after anterior resection for rectal cancer.
    J Surg Oncol. 2019;120:1412-1419.
    PubMed     Abstract available


    November 2019
  76. SHARMA A, Alatise OI, Adisa AO, Arowolo OA, et al
    Treatment of colorectal cancer in Sub-Saharan Africa: Results from a prospective Nigerian hospital registry.
    J Surg Oncol. 2019 Nov 19. doi: 10.1002/jso.25768.
    PubMed     Abstract available


  77. MACARI D, Kawak S, Raofi V, Wasvary H, et al
    Recurrence pattern and outcomes in T4 colon cancer: A single institution analysis.
    J Surg Oncol. 2019 Nov 14. doi: 10.1002/jso.25766.
    PubMed     Abstract available


  78. GAMBOA AC, Liu Y, Lee RM, Zaidi MY, et al
    A novel preoperative risk score to predict lymph node positivity for rectal neuroendocrine tumors: An NCDB analysis to guide operative technique.
    J Surg Oncol. 2019;120:932-939.
    PubMed     Abstract available


  79. CORSINI EM, Mitchell KG, Antonoff MB
    Response to letter to the editor.
    J Surg Oncol. 2019;120:1051-1052.
    PubMed    


  80. POLI EC, Millis AM, Berger Y, Sherman SK, et al
    Implementation of bundled care to reduce surgical site infections after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2019;120:1044-1045.
    PubMed    


    October 2019
  81. LAPORTE GA, Leguisamo NM, Gloria HCE, Azambuja DB, et al
    The role of double-strand break repair, translesion synthesis, and interstrand crosslinks in colorectal cancer progression-clinicopathological data and survival.
    J Surg Oncol. 2019 Oct 25. doi: 10.1002/jso.25737.
    PubMed     Abstract available


  82. ROLFF HC, Christensen IJ, Svendsen LB, Wilhelmsen M, et al
    The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study.
    J Surg Oncol. 2019 Oct 23. doi: 10.1002/jso.25733.
    PubMed     Abstract available


  83. SERRANO PE, Gu CS, Husien M, Jalink D, et al
    Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
    J Surg Oncol. 2019 Oct 14. doi: 10.1002/jso.25735.
    PubMed     Abstract available


  84. HEALY MA, Thirumurthi S, You YN
    Screening high-risk populations for colon and rectal cancers.
    J Surg Oncol. 2019;120:858-863.
    PubMed     Abstract available


    September 2019
  85. FIELDS AC, Lu P, Goldberg J, Irani J, et al
    The role of adjuvant chemotherapy in stage II and III mucinous colon cancer.
    J Surg Oncol. 2019 Sep 19. doi: 10.1002/jso.25705.
    PubMed     Abstract available


  86. LEIJSSEN LGJ, Dinaux AM, Kunitake H, Bordeianou LG, et al
    The impact of postoperative morbidity on survival in patients with metastatic colon and rectal cancer.
    J Surg Oncol. 2019;120:460-472.
    PubMed     Abstract available


  87. GHIASLOO M, Kahya H, Van Langenhove S, Grammens J, et al
    Effect of treatment sequence on survival in stage IV rectal cancer with synchronous and potentially resectable liver metastases.
    J Surg Oncol. 2019;120:415-422.
    PubMed     Abstract available


  88. MAGUIRE LH, Geiger TM, Hardiman KM, Regenbogen SE, et al
    Surgical management of primary colonic lymphoma: Big data for a rare problem.
    J Surg Oncol. 2019;120:431-437.
    PubMed     Abstract available


  89. KYANG LS, Alzahrani NA, Valle SJ, Rahman MK, et al
    Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    J Surg Oncol. 2019;120:794-802.
    PubMed     Abstract available


  90. STUART E, Banerjee S, de la Torre J, Wang Y, et al
    Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
    J Surg Oncol. 2019;120:715-721.
    PubMed     Abstract available


    August 2019
  91. CHEN B
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Aug 26. doi: 10.1002/jso.25687.
    PubMed    


  92. SAITO G, Sadahiro S, Ogimi T, Miyakita H, et al
    Preventive effects of a synthetic absorbable antiadhesive film (seprafilm) on small bowel obstruction in patients who underwent elective surgery for colon cancer: A randomized controlled trial.
    J Surg Oncol. 2019 Aug 7. doi: 10.1002/jso.25664.
    PubMed     Abstract available


  93. HUGHES BD, Hancock KJ, Shan Y, Thakker RA, et al
    Cost of benign versus oncologic colon resection among fee-for-service Medicare enrollees.
    J Surg Oncol. 2019;120:280-286.
    PubMed     Abstract available


  94. FIELDS AC, Melnitchouk N, Senturk J, Irani J, et al
    Early versus late salvage abdominoperineal resection for anal squamous cell carcinoma: Is there a difference in survival?
    J Surg Oncol. 2019;120:287-293.
    PubMed     Abstract available


  95. BAUSYS A, Kuliavas J, Dulskas A, Kryzauskas M, et al
    Early versus standard closure of temporary ileostomy in patients with rectal cancer: A randomized controlled trial.
    J Surg Oncol. 2019;120:294-299.
    PubMed     Abstract available


  96. HARDIMAN KM, Antunez AG, Kanters A, Schuman AD, et al
    Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally-advanced rectal cancer.
    J Surg Oncol. 2019;120:308-315.
    PubMed     Abstract available


    July 2019
  97. DUMONT F, Munoz MA, De Franco V, Wernert R, et al
    Significance of lymph node involvement in local recurrence of colorectal cancer.
    J Surg Oncol. 2019 Jul 22. doi: 10.1002/jso.25631.
    PubMed     Abstract available


  98. CORSINI EM, Mitchell KG, Mehran RJ, Rice DC, et al
    Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.
    J Surg Oncol. 2019 Jul 9. doi: 10.1002/jso.25630.
    PubMed     Abstract available


    June 2019
  99. STELZNER S, Radulova-Mauersberger O, Zschuppe E, Kittner T, et al
    Prognosis in patients with synchronous colorectal cancer metastases after complete resection of the primary tumor and the metastases.
    J Surg Oncol. 2019 Jun 5. doi: 10.1002/jso.25578.
    PubMed     Abstract available


  100. LEMOINE L, Thijssen E, Carleer R, Geboers K, et al
    Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial.
    J Surg Oncol. 2019;119:999-1010.
    PubMed     Abstract available


  101. RAUSA E, Bianco F, Kelly ME, Aiolfi A, et al
    Systemic review and network meta-analysis comparing minimal surgical techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes.
    J Surg Oncol. 2019;119:987-998.
    PubMed     Abstract available


  102. MESQUITA-NETO JWB, Mouzaihem H, Macedo FIB, Heilbrun LK, et al
    Perioperative and oncological outcomes of abdominoperineal resection in the prone position vs the classic lithotomy position: A systematic review with meta-analysis.
    J Surg Oncol. 2019;119:979-986.
    PubMed     Abstract available


    May 2019
  103. KIM HS, Kim KM, Lee SB, Kim GR, et al
    Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: Insight into the survival paradox.
    J Surg Oncol. 2019 May 27. doi: 10.1002/jso.25515.
    PubMed     Abstract available


  104. LORIMER PD, Motz BM, Kirks RC, Han Y, et al
    Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER-Medicare.
    J Surg Oncol. 2019 May 18. doi: 10.1002/jso.25508.
    PubMed     Abstract available


    April 2019
  105. LINO-SILVA LS, Anchondo-Nunez P, Chit-Huerta A, Aguilar-Romero E, et al
    Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients.
    J Surg Oncol. 2019 Apr 24. doi: 10.1002/jso.25482.
    PubMed     Abstract available


  106. ANTONY P, Harnoss JC, Warschkow R, Schmied BM, et al
    Urgent surgery in colon cancer has no impact on survival.
    J Surg Oncol. 2019 Apr 12. doi: 10.1002/jso.25469.
    PubMed     Abstract available


  107. LINECKER M, Kuemmerli C, Clavien PA, Petrowsky H, et al
    Dealing with insufficient liver remnant: Associating liver partition and portal vein ligation for staged hepatectomy.
    J Surg Oncol. 2019;119:604-612.
    PubMed     Abstract available


  108. KAWAGUCHI Y, Lillemoe HA, Vauthey JN
    Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy.
    J Surg Oncol. 2019;119:594-603.
    PubMed     Abstract available


  109. KRELL RW, D'Angelica MI
    Treatment sequencing for simultaneous colorectal liver metastases.
    J Surg Oncol. 2019;119:583-593.
    PubMed     Abstract available


  110. PHILLIPS JD, Hasson RM
    Surgical management of colorectal lung metastases.
    J Surg Oncol. 2019;119:629-635.
    PubMed     Abstract available


  111. DAY RW, Aloia TA
    Enhanced recovery in liver surgery.
    J Surg Oncol. 2019;119:660-666.
    PubMed     Abstract available


  112. MARGONIS GA, Kreis ME, Wolfgang CL, Weiss MJ, et al
    Mutation status and surgical selection.
    J Surg Oncol. 2019;119:616-622.
    PubMed     Abstract available


    March 2019
  113. ENG OS, Turaga KK
    Cytoreduction and hyperthermic intraperitoneal chemotherapy in metastatic colorectal cancer.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25438.
    PubMed     Abstract available


  114. ADVANI S, Kopetz S
    Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials.
    J Surg Oncol. 2019 Mar 10. doi: 10.1002/jso.25441.
    PubMed     Abstract available


  115. ALZAHRANI NA, Valle SJ, Fisher OM, Sugarbaker PH, et al
    Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
    J Surg Oncol. 2019;119:336-346.
    PubMed     Abstract available


  116. PENCOVICH N, Houli R, Lubezky N, Goykhman Y, et al
    R1 resection of colorectal liver metastasis - What is the cost of marginal resection?
    J Surg Oncol. 2019;119:347-354.
    PubMed     Abstract available


  117. CHAPMAN BC, Goodman K, Hosokawa P, Gleisner A, et al
    Improved survival in rectal cancer patients who are treated with long-course versus short-course neoadjuvant radiotherapy: A propensity-matched analysis of the NCDB.
    J Surg Oncol. 2019;119:518-531.
    PubMed     Abstract available


  118. SCLAFANI F, Hesselberg G, Thompson SR, Truskett P, et al
    Multimodality treatment of oligometastatic anal squamous cell carcinoma: A case series and literature review.
    J Surg Oncol. 2019;119:489-496.
    PubMed     Abstract available


  119. SCHLICK CJR, Merkow RP, Bentrem DJ
    Nonresectional regional therapies for metastatic colorectal cancer to the liver.
    J Surg Oncol. 2019 Mar 1. doi: 10.1002/jso.25423.
    PubMed     Abstract available


  120. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Response to the Letter to the Editor.
    J Surg Oncol. 2019;119:399.
    PubMed    


    February 2019
  121. DE ANDRADE JP, Warner SG, Fong Y
    Treatment of metastatic colorectal cancer: innovations in surgical techniques.
    J Surg Oncol. 2019 Feb 27. doi: 10.1002/jso.25418.
    PubMed     Abstract available


  122. LEE RM, Cardona K, Russell MC
    Historical perspective: Two decades of progress in treating metastatic colorectal cancer.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25431.
    PubMed     Abstract available


  123. MELSTROM LG, Tzeng CD
    Metastatic colorectal cancer: The reality of the present and the optimism of the future.
    J Surg Oncol. 2019 Feb 26. doi: 10.1002/jso.25427.
    PubMed    


  124. SANDHU J, Lavingia V, Fakih M
    Systemic treatment for metastatic colorectal cancer in the era of precision medicine.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25421.
    PubMed     Abstract available


  125. BLISS LA, Strong EA, Gamblin TC
    Surgical resectability of multisite metastatic colorectal cancer: Pushing the limits while appropriately selecting patients.
    J Surg Oncol. 2019 Feb 25. doi: 10.1002/jso.25419.
    PubMed     Abstract available


    January 2019
  126. FLYNN SM, Burchette RJ, Ghassemi M, Ratner O, et al
    Carnoy's solution fixation with compression significantly increases the number of lymph nodes yielded from colorectal cancer specimens.
    J Surg Oncol. 2019 Jan 16. doi: 10.1002/jso.25372.
    PubMed     Abstract available


  127. LEIJSSEN LGJ, Dinaux AM, Amri R, Taylor MS, et al
    Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.
    J Surg Oncol. 2019 Jan 15. doi: 10.1002/jso.25367.
    PubMed     Abstract available


  128. YU J, Li N, Tang Y, Wang X, et al
    Outcomes after hypofractionated stereotactic radiotherapy for colorectal cancer oligometastases.
    J Surg Oncol. 2019 Jan 4. doi: 10.1002/jso.25361.
    PubMed     Abstract available


  129. FIELDS AC, McCarty JC, Ma-Pak L, Lu P, et al
    New lymph node staging for rectal neuroendocrine tumors.
    J Surg Oncol. 2019;119:156-162.
    PubMed     Abstract available


    December 2018
  130. LINO-SILVA LS, Guzman-Lopez JC, Zepeda-Najar C, Salcedo-Hernandez RA, et al
    Overall survival of patients with colon cancer and a prolonged time to surgery.
    J Surg Oncol. 2018 Dec 24. doi: 10.1002/jso.25354.
    PubMed     Abstract available


  131. JIANG Z, Sun L, Yang W, Li J, et al
    Excessive expectations for carcinoembryonic antigen targeted fluorescent-guided surgery for sentinel lymph node detection in colorectal, pancreatic, and gastric cancer.
    J Surg Oncol. 2018 Dec 3. doi: 10.1002/jso.25318.
    PubMed    


  132. CHAKEDIS J, Beal EW, Sun S, Galo J, et al
    Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
    J Surg Oncol. 2018;118:1065-1073.
    PubMed     Abstract available


  133. SUAREZ J, Goicoetxea A, Gomez ML, Jimenez G, et al
    Impact of specific modes of circumferential resection margin involvement in rectal cancer local recurrence: A retrospective study.
    J Surg Oncol. 2018;118:1122-1128.
    PubMed     Abstract available


  134. REYNOLDS IS, McNamara DA, Kay EW, O'Neill B, et al
    The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    J Surg Oncol. 2018;118:1129-1134.
    PubMed     Abstract available


    November 2018
  135. MORIS D, Tsilimigras DI, Machairas N, Merath K, et al
    Laparoscopic synchronous resection of colorectal cancer and liver metastases: A systematic review.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25313.
    PubMed     Abstract available


  136. LIAO CK, Chiang JM, Tsai WS, You JF, et al
    Primary tumor location in stage III colon cancer has prognostic impact on subsequent liver metastasis.
    J Surg Oncol. 2018 Nov 8. doi: 10.1002/jso.25270.
    PubMed     Abstract available


  137. CHOUHAN H, Sammour T, Thomas ML, Moore JW, et al
    The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
    J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25275.
    PubMed     Abstract available


    October 2018
  138. KUMAR NAN, Verma K, Shinde RS, Kammar P, et al
    Pulmonary metastasectomy of colorectal cancer origin: Evaluating process and outcomes.
    J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25273.
    PubMed     Abstract available


    September 2018
  139. WATANABE A, Harimoto N, Araki K, Yoshizumi T, et al
    A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25250.
    PubMed     Abstract available


  140. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
    PubMed     Abstract available


  141. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.
    J Surg Oncol. 2018 Sep 14. doi: 10.1002/jso.25139.
    PubMed     Abstract available


  142. MANCEAU G, Mori A, Bardier A, Augustin J, et al
    Lymph node metastases in splenic flexure colon cancer: Is subtotal colectomy warranted?
    J Surg Oncol. 2018 Sep 13. doi: 10.1002/jso.25169.
    PubMed     Abstract available


  143. LI J, Gu J, Ma X, Li X, et al
    Development and validation of a nomogram for predicting survival in Chinese han patients with resected colorectal cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25213.
    PubMed     Abstract available


  144. HU WH, Chen HH, Yen SL, Huang HY, et al
    Re: Increased expression of interleukin-23 associated with progression of colorectal cancer. Journal of Surgical Oncology 2017;115(2):208-212.
    J Surg Oncol. 2018;118:723.
    PubMed    


  145. KERANMU A, Liu HN, Wu YC, Liu TT, et al
    A negative-doughnut distal resection margin less than 5 mm does not affect prognosis in rectal cancer.
    J Surg Oncol. 2018;118:536-543.
    PubMed     Abstract available


  146. TANG Y, Rao S, Yang C, Hu Y, et al
    Value of MRI morphologic features with pT1-2 rectal cancer in determining lymph node metastasis.
    J Surg Oncol. 2018;118:544-550.
    PubMed     Abstract available


    August 2018
  147. HENTZEN JEKR, de Jongh SJ, Hemmer PHJ, van der Plas WY, et al
    Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review.
    J Surg Oncol. 2018;118:332-343.
    PubMed     Abstract available


    July 2018
  148. KRUGER JAP, Fonseca GM, Makdissi FF, Jeismann VB, et al
    Evolution in the surgical management of colorectal liver metastases: Propensity score matching analysis (PSM) on the impact of specialized multidisciplinary care across two institutional eras.
    J Surg Oncol. 2018;118:50-60.
    PubMed     Abstract available


    June 2018
  149. LE SOUDER E, Azin A, Wood T, Hirpara D, et al
    The effect of a simultaneous versus a staged resection of metastatic colorectal cancer on time to adjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25122.
    PubMed     Abstract available


  150. SIDERAS K, Galjart B, Vasaturo A, Pedroza-Gonzalez A, et al
    Prognostic value of intra-tumoral CD8(+) /FoxP3(+) lymphocyte ratio in patients with resected colorectal cancer liver metastasis.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25091.
    PubMed     Abstract available


  151. ZAIMI I, Sparreboom CL, Lingsma HF, Doornebosch PG, et al
    The effect of age on anastomotic leakage in colorectal cancer surgery: A population-based study.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25108.
    PubMed     Abstract available


  152. LI J, Wang Y, Liu D, Zhou H, et al
    Multidimensional analyses of the learning curve for single-incision plus one port laparoscopic surgery for sigmoid colon and upper rectal cancer.
    J Surg Oncol. 2018;117:1386-1393.
    PubMed     Abstract available


  153. FONSECA GM, de Mello ES, Faraj SF, Kruger JAP, et al
    Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases.
    J Surg Oncol. 2018;117:1364-1375.
    PubMed     Abstract available


  154. CHO MS, Park YY, Yoon J, Yang SY, et al
    MRI-based EMVI positivity predicts systemic recurrence in rectal cancer patients with a good tumor response to chemoradiotherapy followed by surgery.
    J Surg Oncol. 2018;117:1823-1832.
    PubMed     Abstract available


    May 2018
  155. CHOE EK, Yi JW, Chai YJ, Park KJ, et al
    Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer.
    J Surg Oncol. 2018 May 14. doi: 10.1002/jso.25078.
    PubMed     Abstract available


  156. DUPRE A, Rehman A, Jones RP, Parker A, et al
    Validation of clinical prognostic scores for patients treated with curative-intent for recurrent colorectal liver metastases.
    J Surg Oncol. 2018;117:1330-1336.
    PubMed     Abstract available


  157. DINAUX AM, Leijssen LGJ, Bordeianou LG, Kunitake H, et al
    Effects of local multivisceral resection for clinically locally advanced rectal cancer on long-term outcomes.
    J Surg Oncol. 2018;117:1323-1329.
    PubMed     Abstract available


    April 2018
  158. MIYAMOTO E, Chen-Yoshikawa TF, Ueshima C, Yoshizawa A, et al
    Transition of the programmed death 1 pathway from the primary colorectal cancer to its corresponding pulmonary metastasis.
    J Surg Oncol. 2018 Apr 17. doi: 10.1002/jso.25045.
    PubMed     Abstract available


  159. MARQUES MC, C Ribeiro HS, Costa WL Jr., de Jesus VHF, et al
    Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
    J Surg Oncol. 2018 Apr 2. doi: 10.1002/jso.25048.
    PubMed     Abstract available


  160. ZHONG A, Tian Y, Zhang H, Lai M, et al
    DNA hydroxymethylation of colorectal primary carcinoma and its association with survival.
    J Surg Oncol. 2018;117:1029-1037.
    PubMed     Abstract available


  161. BOGACH J, Tsai S, Zbuk K, Wong R, et al
    Quality of preoperative pelvic computed tomography (CT) and magnetic resonance imaging (MRI) for rectal cancer in a region in Ontario: A retrospective population-based study.
    J Surg Oncol. 2018;117:1038-1042.
    PubMed     Abstract available


  162. JUSTINGER C, Gruden J, Kouladouros K, Stravodimos C, et al
    Histopathological changes resulting from selective internal radiotherapy (SIRT).
    J Surg Oncol. 2018;117:1084-1091.
    PubMed     Abstract available


  163. MCCLUNEY SJ, Giakoustidis A, Segler A, Bissel J, et al
    Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis.
    J Surg Oncol. 2018;117:1058-1065.
    PubMed     Abstract available


    March 2018
  164. BAGANTE F, Spolverato G, Beal E, Merath K, et al
    Impact of histological subtype on the prognosis of patients undergoing surgery for colon cancer.
    J Surg Oncol. 2018 Mar 25. doi: 10.1002/jso.25044.
    PubMed     Abstract available


  165. CHEN ST, Wu MC, Hsu TC, Yen DW, et al
    Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data.
    J Surg Oncol. 2018;117:497-505.
    PubMed     Abstract available


  166. LEE SY, Kim CH, Kim YJ, Kim HR, et al
    Prognostic significance of the distribution of lymph node metastasis in rectal cancer after neoadjuvant chemoradiation.
    J Surg Oncol. 2018;117:514-522.
    PubMed     Abstract available


  167. SESHADRI RA, Swaminathan R, Srinivasan A
    Laparoscopic versus open surgery for rectal cancer after neoadjuvant chemoradiation: Long-term outcomes of a propensity score matched study.
    J Surg Oncol. 2018;117:506-513.
    PubMed     Abstract available


  168. CABELLOS OLIVARES M, Labalde Martinez M, Torralba M, Rodriguez Fraile JR, et al
    C-reactive protein as a marker of the surgical stress reduction within an ERAS protocol (Enhanced Recovery After Surgery) in colorectal surgery: A prospective cohort study.
    J Surg Oncol. 2018;117:717-724.
    PubMed     Abstract available


  169. SUN Y, Zhang Y, Wu X, Lin H, et al
    Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.
    J Surg Oncol. 2018;117:737-744.
    PubMed     Abstract available


  170. AMIKURA K, Akagi K, Ogura T, Takahashi A, et al
    The RAS mutation status predicts survival in patients undergoing hepatic resection for colorectal liver metastases: The results from a genetic analysis of all-RAS.
    J Surg Oncol. 2018;117:745-755.
    PubMed     Abstract available


  171. FISHER SB, Rafeeq S, Hess K, Grotz TE, et al
    Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC).
    J Surg Oncol. 2018;117:685-691.
    PubMed     Abstract available


  172. PAK LM, Kemeny NE, Capanu M, Chou JF, et al
    Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    J Surg Oncol. 2018;117:634-643.
    PubMed     Abstract available


  173. IHNAT P, Slivova I, Tulinsky L, Ihnat Rudinska L, et al
    Anorectal dysfunction after laparoscopic low anterior rectal resection for rectal cancer with and without radiotherapy (manometry study).
    J Surg Oncol. 2018;117:710-716.
    PubMed     Abstract available


    February 2018
  174. LE SOUDER EB, Azin A, Hirpara DH, Walker R, et al
    Considering the cost of a simultaneous versus staged approach to resection of colorectal cancer with synchronous liver metastases in a publicly funded healthcare model.
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25020.
    PubMed     Abstract available


  175. WALKER R, Wood T, LeSouder E, Cleghorn M, et al
    Comparison of two novel staging systems with the TNM system in predicting stage III colon cancer survival.
    J Surg Oncol. 2018 Feb 23. doi: 10.1002/jso.25009.
    PubMed     Abstract available


  176. HUIJBERS A, van Pelt GW, Kerr RS, Johnstone EC, et al
    The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trial.
    J Surg Oncol. 2018 Feb 15. doi: 10.1002/jso.24998.
    PubMed     Abstract available


  177. IDREES K, Padmanabhan C, Liu E, Guo Y, et al
    Frequent BRAF mutations suggest a novel oncogenic driver in colonic neuroendocrine carcinoma.
    J Surg Oncol. 2018;117:284-289.
    PubMed     Abstract available


  178. GRAVANTE G, Stephenson JA, Elshaer M, Osman A, et al
    Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
    J Surg Oncol. 2018;117:269-274.
    PubMed     Abstract available


  179. TANI K, Shindoh J, Akamatsu N, Arita J, et al
    Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors.
    J Surg Oncol. 2018;117:191-197.
    PubMed     Abstract available


    December 2017
  180. KOZMAN MA, Fisher OM, Rebolledo BJ, Parikh R, et al
    CEA to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with colorectal cancer peritoneal carcinomatosis undergoing cytoreduction surgery and intraperitoneal chemotherapy: A retrospective cohort study.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24911.
    PubMed     Abstract available


  181. IWAI T, Yamada T, Koizumi M, Shinji S, et al
    Oxaliplatin-induced increase in splenic volume; irreversible change after adjuvant FOLFOX.
    J Surg Oncol. 2017;116:947-953.
    PubMed     Abstract available


  182. GOTO S, Hida K, Kawada K, Okamura R, et al
    Multicenter analysis of transanal tube placement for prevention of anastomotic leak after low anterior resection.
    J Surg Oncol. 2017;116:989-995.
    PubMed     Abstract available


  183. MARGONIS GA, Buettner S, Andreatos N, Sasaki K, et al
    Preoperative bevacizumab and volumetric recovery after resection of colorectal liver metastases.
    J Surg Oncol. 2017;116:1150-1158.
    PubMed     Abstract available


  184. AL-NAJAMI I, Drue HC, Steele R, Baatrup G, et al
    Dual energy CT - a possible new method to assess regression of rectal cancers after neoadjuvant treatment.
    J Surg Oncol. 2017;116:984-988.
    PubMed     Abstract available


    November 2017
  185. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    PubMed     Abstract available


  186. CHOE EK, Park KJ, Ryoo SB, Moon SH, et al
    The impact of visceral adipose tissue amount on the adequacy of lymph node retrieval in colorectal cancer surgery.
    J Surg Oncol. 2017 Nov 9. doi: 10.1002/jso.24876.
    PubMed     Abstract available


  187. VAN DE PUTTE D, Van Daele E, Willaert W, Pattyn P, et al
    Effect of abdominopelvic sepsis on cancer outcome in patients undergoing sphincter saving surgery for rectal cancer.
    J Surg Oncol. 2017;116:722-729.
    PubMed     Abstract available


    October 2017
  188. JOSHI HM, Keller DS, Chand M
    Utilization of Indocyanine green to demonstrate lymphatic mapping in colon cancer.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24795.
    PubMed    


  189. MANSO M, Schmelz J, Aloia T
    ERAS-Anticipated outcomes and realistic goals.
    J Surg Oncol. 2017;116:570-577.
    PubMed     Abstract available


    September 2017
  190. SASAKI K, Margonis GA, Andreatos N, Zhang XF, et al
    The prognostic utility of the "Tumor Burden Score" based on preoperative radiographic features of colorectal liver metastases.
    J Surg Oncol. 2017;116:515-523.
    PubMed     Abstract available


    May 2017
  191. LANGAN RC, Goldman DA, D'Angelica MI, DeMatteo RP, et al
    Recurrence patterns following irreversible electroporation for hepatic malignancies.
    J Surg Oncol. 2017;115:704-710.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: